ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of MEDI-522 On Disease Activity and Progression of Joint Damage in Patients With Active Rheumatoid Arthritis Suboptimally Responding to Methotrexate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00069017
Recruitment Status : Completed
First Posted : September 17, 2003
Last Update Posted : November 27, 2007
Sponsor:
Information provided by:
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : April 2006